Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab
Clinical trial NCT06931652 · RECRUITING
Trial details
- NCT number
- NCT06931652
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2028-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.